{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:42:44Z","timestamp":1780393364014,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.taap.2016.12.011","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T22:48:00Z","timestamp":1482187680000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Gemcitabine: Selective cytotoxicity, induction of inflammation and effects on urothelial function"],"prefix":"10.1016","volume":"316","author":[{"given":"Stefanie E","family":"Farr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russ","family":"Chess-Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2016.12.011_bb0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1200\/JCO.2008.20.8199","article-title":"Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: evaluation of efficacy and tolerance","volume":"28","author":"Addeo","year":"2010","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.taap.2016.12.011_bb0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0031-6997(25)00442-9","article-title":"Pharmacology of lower urinary tract smooth muscles and penile erectile tissues","volume":"45","author":"Anderson","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.taap.2016.12.011_bb0015","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1259\/bjr\/54004230","article-title":"Resazurin assay of radiation response in cultured cells","volume":"78","author":"Anoopkumar-Dukie","year":"2005","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.taap.2016.12.011_bb0020","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.phrs.2011.06.009","article-title":"Muscarinic receptors stimulate cell proliferation in the human urothelium-derived cell line UROtsa","volume":"64","author":"Arrighi","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.taap.2016.12.011_bb0025","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-3-642-16499-6_10","article-title":"Urothelial signaling","author":"Birder","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.taap.2016.12.011_bb0035","first-page":"843","article-title":"Stromal and vascular invasion in an human in vitro bladder cancer model","volume":"76","author":"Booth","year":"1997","journal-title":"Lab. Investig."},{"key":"10.1016\/j.taap.2016.12.011_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0100-879X2008005000037","article-title":"Purinergic signalling: past, present and future","volume":"42","author":"Burnstock","year":"2009","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.taap.2016.12.011_bb0045","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s12032-009-9349-y","article-title":"Pharmacogenetics and pharmacoepigenetics of gemcitabine","volume":"27","author":"Candelaria","year":"2010","journal-title":"Med. Oncol."},{"key":"10.1016\/j.taap.2016.12.011_bb0050","doi-asserted-by":"crossref","first-page":"8507","DOI":"10.1002\/chem.200700260","article-title":"Understanding ribonucleotide reductase inactivation by gemcitabine","volume":"13","author":"Cerqueira","year":"2007","journal-title":"Chemistry"},{"key":"10.1016\/j.taap.2016.12.011_bb0055","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1007\/s11064-008-9711-z","article-title":"Intracellular signaling in primary sensory neurons and persistent pain","volume":"33","author":"Cheng","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.taap.2016.12.011_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fphar.2011.00027","article-title":"Porcine bladder urothelial, myofibroblast, and detrusor muscle cells: characterization and ATP release","volume":"2","author":"Cheng","year":"2011","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2016.12.011_bb0065","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1464-410X.2010.09654.x","article-title":"Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC)","volume":"107","author":"Colombo","year":"2011","journal-title":"BJU Int."},{"key":"10.1016\/j.taap.2016.12.011_bb0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.eururo.2009.12.030","article-title":"The inhibitory role of acetylcholine and muscarinic receptors in bladder afferent activity","volume":"58","author":"Daly","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.taap.2016.12.011_bb0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bcp.2009.07.018","article-title":"Cytotoxic activity of gemcitabine in cultured cell lines derived from histologically different types of bladder cancer: role of thymidine kinase 2","volume":"79","author":"Damaraju","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.taap.2016.12.011_bb0080","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.taap.2016.12.011_bb0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1074\/jbc.M508857200","article-title":"Interleukin-8 secretion by fibroblasts induced by low density lipoproteins is p38 MAPK-dependent and leads to cell spreading and wound closure","volume":"281","author":"Dobreva","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2016.12.011_bb0090","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bbamcr.2007.05.002","article-title":"Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine","volume":"1773","author":"Donadelli","year":"2007","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Cell Res."},{"key":"10.1016\/j.taap.2016.12.011_bb0095","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0022-5347(05)65005-7","article-title":"A comparison of multiple urine markers for interstitial cystitis","volume":"167","author":"Erickson","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.taap.2016.12.011_bb0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.taap.2009.12.029","article-title":"Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model","volume":"244","author":"Escudero-Lourdes","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2016.12.011_bb0105","first-page":"4826s","article-title":"Pathological effects of hyperthermia in normal tissues","volume":"44","author":"Fajardo","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2016.12.011_bb0110","first-page":"3675","article-title":"Modulatory activity of 2\u2032,2\u2032-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides","volume":"50","author":"Gandhi","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2016.12.011_bb0115","first-page":"4453","article-title":"Excision of 2\u2032,2\u2032-difluorodeoxycytidine (gemcitabine) monophosphate residues from DNA","volume":"56","author":"Gandhi","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2016.12.011_bb0120","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1155\/2014\/120525","article-title":"The role(s) of cytokines\/chemokines in urinary bladder inflammation and dysfunction","volume":"2014","author":"Gonzalez","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.taap.2016.12.011_bb0125","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.lfs.2007.02.010","article-title":"Non-neuronal acetylcholine and urinary bladder urothelium","volume":"80","author":"Hanna-Mitchell","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2016.12.011_bb0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2012.11.053","article-title":"Induction of inflammatory cytokines and alteration of urothelial ATP, acetylcholine and prostaglandin E2 release by doxorubicin","volume":"700","author":"Kang","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2016.12.011_bb0135","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00210-015-1092-7","article-title":"Recovery of urothelial mediator release but prolonged elevations in interleukin-8 and nitric oxide secretion following mitomycin C treatment","volume":"388","author":"Kang","year":"2015","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.taap.2016.12.011_bb0140","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00001813-200207000-00002","article-title":"Selective cytotoxicity of gemcitabine in bladder cancer cell lines","volume":"13","author":"Kilani","year":"2002","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.taap.2016.12.011_bb0145","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0022-5347(06)00264-3","article-title":"Complications of intravesical therapy for urothelial cancer of the bladder","volume":"175","author":"Koya","year":"2006","journal-title":"J. Urol."},{"key":"10.1016\/j.taap.2016.12.011_bb0150","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/01.mou.0000172393.52857.92","article-title":"Recent advances in basic science for overactive bladder","volume":"15","author":"Kumar","year":"2005","journal-title":"Curr. Opin. Urol."},{"key":"10.1016\/j.taap.2016.12.011_bb0155","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2011.04.023","article-title":"The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review","volume":"60","author":"Lammers","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.taap.2016.12.011_bb0160","first-page":"5070","article-title":"Establishment and characterization of four human bladder tumor cell lines and sublines with different degrees of malignancy","volume":"45","author":"Lin","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.taap.2016.12.011_bb0165","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0022-5347(17)32594-6","article-title":"Interleukin-6 and interstitial cystitis","volume":"152","author":"Lotz","year":"1994","journal-title":"J. Urol."},{"key":"10.1016\/j.taap.2016.12.011_bb0170","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10753-011-9319-3","article-title":"Interleukin-4 modulates the inflammatory response in Ifosfamide-induced hemorrhagic cystitis","volume":"35","author":"Macedo","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.taap.2016.12.011_bb0175","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drup.2004.01.004","article-title":"ROS stress in cancer cells and therapeutic implications","volume":"7","author":"Pelicano","year":"2004","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.taap.2016.12.011_bb0180","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0014-2999(99)00833-X","article-title":"Prostaglandin-release impairment in the bladder epithelium of streptozotocin-induced diabetic rats","volume":"388","author":"Pinna","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.taap.2016.12.011_bb0185","first-page":"3","article-title":"Gemcitabine: metabolism, mechanisms of action, and self-potentiation","volume":"22","author":"Plunkett","year":"1995","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.taap.2016.12.011_bb0190","first-page":"1149","article-title":"Hyperthermia as a treatment for bladder cancer","volume":"24","author":"Rampersaud","year":"2010","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.taap.2016.12.011_bb0195","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/S0022-5347(05)65134-8","article-title":"Tumor necrosis factor-\u03b1 and interleukin-1\u03b2 mediate the production of nitric oxide involved in the pathogenesis of Ifosfamide induced hemorrhagic cystitis in mice","volume":"167","author":"Ribeiro","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.taap.2016.12.011_bb0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/09687680010026313","volume":"18","author":"Ritzel","year":"2001","journal-title":"Mol. Membr. Biol."},{"key":"10.1016\/j.taap.2016.12.011_bb0205","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1289\/ehp.01109801","article-title":"The immortalized UROtsa cell line as a potential cell culture model of human urothelium","volume":"109","author":"Rossi","year":"2001","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.taap.2016.12.011_bb0210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ctrv.2009.12.005","article-title":"Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses","volume":"36","author":"Shelley","year":"2010","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.taap.2016.12.011_bb0215","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1464-410X.2011.10880.x","article-title":"Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review","volume":"109","author":"Shelley","year":"2012","journal-title":"BJU Int."},{"key":"10.1016\/j.taap.2016.12.011_bb0220","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.juro.2010.09.042","article-title":"Modulation of stretch evoked adenosine triphosphate release from bladder epithelium by prostaglandin E(2)","volume":"185","author":"Tanaka","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.taap.2016.12.011_bb0225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0094-0143(21)00419-5","article-title":"Complications of intravesical chemotherapy","volume":"19","author":"Thrasher","year":"1992","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.taap.2016.12.011_bb0230","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s11255-009-9647-5","article-title":"Urine cytokines suggest an inflammatory response in the overactive bladder: a pilot study","volume":"42","author":"Tyagi","year":"2010","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.taap.2016.12.011_bb0235","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/01.ju.0000146274.85012.e1","article-title":"Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study","volume":"173","author":"van der Heijden","year":"2005","journal-title":"J. Urol."},{"key":"10.1016\/j.taap.2016.12.011_bb0240","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/annonc\/mdf280","article-title":"Heating the patient: a promising approach?","volume":"13","author":"van der Zee","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.taap.2016.12.011_bb0245","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0014-5793(98)01711-6","article-title":"Human thymidine kinase 2: molecular cloning and characterisation of the enzyme activity with antiviral and cytostatic nucleoside substrates","volume":"443","author":"Wang","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.taap.2016.12.011_bb0250","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1464-410X.2003.03802.x","article-title":"The role of the human bladder lamina propria myofibroblast","volume":"91","author":"Wiseman","year":"2003","journal-title":"BJU Int."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X16303891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X16303891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T19:12:22Z","timestamp":1749841942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X16303891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":49,"alternative-id":["S0041008X16303891"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2016.12.011","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gemcitabine: Selective cytotoxicity, induction of inflammation and effects on urothelial function","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2016.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}